|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Sep―12 |
Intranasal Route: A Nasocerebral Approach against SARS-CoV-2 in NeuroCOVID |
Abdul Mannan Baig, Joachim Gerlach |
2 |
[GO] |
2023―May―12 |
ACE2 Receptor and TMPRSS2 Protein Expression Patterns in the Human Brainstem Reveal Anatomical Regions Potentially Vulnerable to SARS-CoV-2 Infection |
Aron Emmi, Aleksandar Tushevski, Alessandro Sinigaglia, Silvia Barbon, Michele Sandre, Elena Stocco, et al. (+5) Veronica Macchi, Angelo Antonini, Luisa Barzon, Andrea Porzionato, Raffaele De Caro |
3 |
[GO] |
2023―Feb―06 |
SARS-CoV-2 Spike Protein Downregulates Cell Surface α7nAChR through a Helical Motif in the Spike Neck |
Tommy S. Tillman, Qiang Chen, Vasyl Bondarenko, Jonathan A. Coleman, Yan Xu, Pei Tang |
4 |
[GO] |
2022―Oct―03 |
Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID |
Abdul Mannan Baig, Nigel H. Greig, Joachim Gerlach, Prakash Salunke, Mark Fabrowski, Valentina Viduto, Tazeen Ali |
5 |
[GO] |
2022―Apr―02 |
Correlating Biochemical and Structural Changes in the Brain with Clinical Features in COVID-19 |
Abdul Mannan Baig |
6 |
[GO] |
2022―Jan―20 |
Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV-2 |
Artem Pliss, Andrey N. Kuzmin, Paras N. Prasad, Supriya D. Mahajan |
7 |
[GO] |
2021―Dec―03 |
Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation |
Slav A. Semerdzhiev, Mohammad A. A. Fakhree, Ine Segers-Nolten, Christian Blum, Mireille M. A. E. Claessens |
8 |
[GO] |
2021―Nov―15 |
Pathways and Pathogenesis of Hearing Deficits, Tinnitus, and Vertigo in COVID-19 |
Abdul Mannan Baig |
9 |
[GO] |
2021―Oct―06 |
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments |
Raziyeh Najafloo, Jila Majidi, Alimohamad Asghari, Mina Aleemardani, Seyed Kamran Kamrava, Sara Simorgh, et al. (+3) Amelia Seifalian, Zohreh Bagher, Alexander M. Seifalian |
10 |
[GO] |
2021―Sep―17 |
The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia |
Christopher S. von Bartheld, Molly M. Hagen, Rafal Butowt |
11 |
[GO] |
2021―Aug―03 |
Brain Imaging in COVID-19 |
Avantika Samkaria, Pravat Kumar Mandal |
12 |
[GO] |
2021―Jul―14 |
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis |
Vitalakumar D, Ankita Sharma, Anoop Kumar, S. J. S. Flora |
13 |
[GO] |
2021―Jul―06 |
Targeting Neuroinvasion by SARS-CoV-2: Emerging Trends in Drug and Antibody Delivery to Combat COVID-19 |
Abdul Mannan Baig |
14 |
[GO] |
2021―Jul―02 |
COVID-19 as a Trigger of Brain Autoimmunity |
Mayuri Gupta, Donald F. Weaver |
15 |
[GO] |
2021―Jul―01 |
Comment on “Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak” |
Omar Rabab’h, Ali Al-Ramadan, Abeer Gharaibeh |
16 |
[GO] |
2021―Jun―08 |
Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19 |
Mahdi Eskandarian Boroujeni, Leila Simani, Hans A. R. Bluyssen, Hamid Reza Samadikhah, Soheila Zamanlui Benisi, Sanaz Hassani, et al. (+8) Nader Akbari Dilmaghani, Mobina Fathi, Kimia Vakili, Gholam-Reza Mahmoudiasl, Hojjat Allah Abbaszadeh, Meysam Hassani Moghaddam, Mohammad-Amin Abdollahifar, Abbas Aliaghaei |
17 |
[GO] |
2021―Mar―31 |
Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry |
Samantha Perez-Miller, Marcel Patek, Aubin Moutal, Paz Duran, Carly R. Cabel, Curtis A. Thorne, et al. (+2) Samuel K. Campos, Rajesh Khanna |
18 |
[GO] |
2021―Feb―19 |
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine |
Kartikay Prasad, Shahzaib Ahamad, Hema Kanipakam, Dinesh Gupta, Vijay Kumar |
19 |
[GO] |
2021―Feb―10 |
Chemosensory Systems in COVID-19: Evolution of Scientific Research |
Sheila Veronese, Andrea Sbarbati |
20 |
[GO] |
2021―Feb―02 |
Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters |
Shinji Urata, Junki Maruyama, Megumi Kishimoto-Urata, Rachel A. Sattler, Rebecca Cook, Nantian Lin, et al. (+3) Tatsuya Yamasoba, Tomoko Makishima, Slobodan Paessler |
21 |
[GO] |
2020―Dec―18 |
Could Simultaneous Nasal and Oral Irrigation Be a Nontherapeutic Tool against SARS-CoV-2? |
Bharat Baruah |
22 |
[GO] |
2020―Dec―05 |
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome |
Abdul Mannan Baig |
23 |
[GO] |
2020―Dec―03 |
Could Artesunate Have a Positive Effect on the Neurological Complications Related to Infection When It Is Used in the Treatment of COVID-19? |
Tuğçenur Uzun, Orçun Toptaş, Şule Aydın Türkoğlu |
24 |
[GO] |
2020―Nov―27 |
Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders |
Cristian Follmer |
25 |
[GO] |
2020―Nov―16 |
COVID-19 and Body Iron: A Survey on Phenomenological and Genetic Correlations |
Rüdiger Lawaczeck |
26 |
[GO] |
2020―Nov―05 |
COVID-19: Oxidative Preconditioning as a Potential Therapeutic Approach |
Rachid Akki, Nada Fath, Hicham Mohti |
27 |
[GO] |
2020―Nov―04 |
Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection |
Omid Tavassoly, Farinaz Safavi, Iman Tavassoly |
28 |
[GO] |
2020―Nov―03 |
Toward COVID-19 Therapeutics: A Viewpoint from the Nonprotein Amino Acid Based Synthetic Peptide Design Approach |
Sayan Bhattacharjee |
29 |
[GO] |
2020―Oct―29 |
Can Neurotropic Free-Living Amoeba Serve as a Model to Study SARS-CoV-2 Pathogenesis? |
Abdul Mannan Baig |
30 |
[GO] |
2020―Oct―08 |
Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain? |
Abdul Mannan Baig |
31 |
[GO] |
2020―Sep―30 |
Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor |
Rafal Butowt, Katarzyna Bilinska, Christopher S. Von Bartheld |
32 |
[GO] |
2020―Sep―29 |
SARS-CoV-2: Disinfection Strategies to Prevent Transmission of Neuropathogens via Air Conditioning Systems |
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan |
33 |
[GO] |
2020―Sep―23 |
Brain and COVID-19 crosstalk: pathophysiological and psychological manifestations |
Kalyani Verma, Amitabh ., Dipti N. Prasad, Bhuvnesh Kumar, Ekta Kohli |
34 |
[GO] |
2020―Sep―18 |
Irrigation System and COVID-19 Recurrence: A Potential Risk Factor in the Transmission of SARS-CoV-2 |
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan |
35 |
[GO] |
2020―Sep―03 |
Correlation between CNS Tuberculosis and the COVID-19 Pandemic: The Neurological and Therapeutic Insights |
Narattam Mandal, Nayan De, Pulak Jana, Achinta Sannigrahi, Krishnananda Chattopadhyay |
36 |
[GO] |
2020―Sep―01 |
Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences |
CHRISTOPHER S. VON BARTHELD, Molly M. Hagen, Rafal Butowt |
37 |
[GO] |
2020―Aug―26 |
Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses |
Francisco J. Barrantes |
38 |
[GO] |
2020―Aug―25 |
iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2 |
Xiao-Yuan Mao, Wei-Lin Jin |
39 |
[GO] |
2020―Aug―13 |
SARS-CoV-2: The Increasing Importance of Water Filtration against Highly Pathogenic Microbes |
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan |
40 |
[GO] |
2020―Aug―04 |
Taste and smell disorders in COVID-19 patients: role of Interleukin-6 |
Angela Pia Cazzolla, Roberto Lovero, Lorenzo Lo Muzio, Nunzio Francesco Testa, Annalisa Schirinzi, Giuseppe Palmieri, et al. (+9) Pietro Pozzessere, Vito Procacci, Mariasevera Di Comite, Domenico Ciavarella, Maria Teresa Pepe, Caterina De Ruvo, Vito Crincoli, Francesca Di Serio, Luigi Santacroce |
41 |
[GO] |
2020―Jul―27 |
Fragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19 |
Abdulrahman Alharthy, Fahad Faqihi, Ziad A. Memish, Dimitrios Karakitsos |
42 |
[GO] |
2020―Jul―27 |
Homo sapiens versus SARS-CoV-2 |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
43 |
[GO] |
2020―Jul―24 |
Lung Injury in COVID-19-An Emerging Hypothesis |
Abdulrahman Alharthy, Fahad Faqihi, Ziad A. Memish, Dimitrios Karakitsos |
44 |
[GO] |
2020―Jul―16 |
Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism |
Katarzyna Bilinska, Rafal Butowt |
45 |
[GO] |
2020―Jul―14 |
Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer’s Dementia Patients with SARS-CoV-2 Infection |
Chhanda Charan Danta |
46 |
[GO] |
2020―Jul―14 |
Can the Environmental Phagocyte Acanthamoeba Be a Useful Model to Study SARS-CoV-2 Pathogenicity, Infectivity, and Evasion of Cellular Immune Defenses? |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
47 |
[GO] |
2020―Jul―08 |
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection |
Chhanda Charan Danta |
48 |
[GO] |
2020―Jul―06 |
Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms |
Kambiz Hassanzadeh, Helena Perez Pena, Jessica Dragotto, Lucia Buccarello, Federico Iorio, Stefano Pieraccini, et al. (+2) Giulio Sancini, Marco Feligioni |
49 |
[GO] |
2020―Jul―01 |
Taste and Smell Impairment in SARS-CoV-2 Recovers Early and Spontaneously: Experimental Data Strongly Linked to Clinical Data |
Ibrahim Sayin, Zahide Mine Yazici |
50 |
[GO] |
2020―Jun―30 |
Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19 |
Abdul Mannan Baig |
51 |
[GO] |
2020―Jun―12 |
Happy Hypoxemia in COVID-19-A Neural Hypothesis |
Anoop U.R., Kavita Verma |
52 |
[GO] |
2020―Jun―11 |
Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia |
Abolfazl Torabi, Esmaeil Mohammadbagheri, Nader Akbari Dilmaghani, Amir-Hossein Bayat, Mobina Fathi, Kimia Vakili, et al. (+6) Rafieh Alizadeh, Omidvar Rezaeimirghaed, Mohammadreza Hajiesmaeili, Mahtab Ramezani, Leila Simani, Abbas Aliaghaei |
53 |
[GO] |
2020―Jun―11 |
Targeting SARS-CoV-2: Novel Source of Antiviral Compound(s) against COVID-19? |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
54 |
[GO] |
2020―Jun―03 |
SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis. |
Chitra Mohinder Singh Singal, Paritosh Jaiswal, Pankaj Seth |
55 |
[GO] |
2020―Jun―02 |
Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak |
Xi-Xi Yin, Xiang-Rong Zheng, Wang Peng, Mao-Lan Wu, Xiao-Yuan Mao |
56 |
[GO] |
2020―May―29 |
Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19 |
Abdul Mannan Baig, Erin C. Sanders |
57 |
[GO] |
2020―May―26 |
Immunity-Boosting Spices and the Novel Coronavirus |
Yehya Elsayed, Naveed Ahmed Khan |
58 |
[GO] |
2020―May―20 |
Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19 |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
59 |
[GO] |
2020―May―19 |
Autonomic Brain Centers and Pathophysiology of COVID-19 |
Fatiha Chigr, Mohamed Merzouki, Mohamed Najimi |
60 |
[GO] |
2020―May―07 |
Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. |
Katarzyna Bilinska, Patrycja Jakubowska, CHRISTOPHER S. VON BARTHELD, Rafal Butowt |
61 |
[GO] |
2020―Apr―29 |
Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
Sonu Gandhi, Amit Kumar Srivastava, Upasana Ray, Prem Prakash Tripathi |
62 |
[GO] |
2020―Apr―28 |
Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement |
Abdul Mannan Baig |
63 |
[GO] |
2020―Apr―22 |
Neurological Insights of COVID-19 Pandemic |
Gaurav Das, Nabanita Mukherjee, Surajit Ghosh |
64 |
[GO] |
2020―Apr―13 |
War on Terror Cells: Strategies to Eradicate “Novel Coronavirus” Effectively |
Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
65 |
[GO] |
2020―Mar―31 |
Is Regional Anesthesia Enough Safe in Suspected or Confirmed COVID-19 Patients? |
Reza Aminnejad, Hamed Shafiee |
66 |
[GO] |
2020―Mar―13 |
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms |
Abdul Mannan Baig, Areeba Khaleeq, Usman Ali, Hira Syeda |